Apogee Therapeutics, Inc.
APGEDelisted Sep 3, 2026- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001974640
Apogee Therapeutics, Inc. was delisted on Sep 3, 2026; its insiders filed their last Form 4 on Sep 3, 2026; 288 institutions reported holding it in 13F filings for Q2 2026, worth $8.93B in total; Soros Fund Management was the only superinvestor holding it.
Holders of 5% or more of APGE
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Apogee Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| FMR LLC | 13G/A | 15.00%6.91M shares | – | Aug 6, 20251 filing | Aug 6, 2025 | SEC |
| T. Rowe Price Investment Management, Inc. | 13G | 11.30%6.21M shares | New | Mar 6, 20261 filing | Mar 6, 2026 | SEC |
| Fairmount Funds Management LLC | 13D/A | 9.99%6.81M shares | 0.00 ppfrom 9.99% | Oct 14, 20254 filings | Jun 23, 2026 | SEC |
| Wellington Management Group LLP | 13G/A | 8.70%4.75M shares | −1.90 ppfrom 10.60% | May 12, 20254 filings | Feb 10, 2026 | SEC |
| BlackRock, Inc. | 13G/A | 5.50%2.52M shares | – | Jul 16, 20251 filing | Jul 16, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
16 Schedule 13D and 13G filings on Apogee Therapeutics, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Jun 23, 20265:00 PM ET | Fairmount Funds Management LLCand 3 others | 13D/A | 9.99%6.81M shares | 0.00 ppfrom 9.99% | Jun 18, 2026 | SEC |
| Mar 27, 20265:30 PM ET | Fairmount Funds Management LLCand 3 others | 13D/A | 9.99%6.76M shares | 0.00 ppfrom 9.99% | Mar 26, 2026 | SEC |
| Mar 26, 20263:42 PM ET | Vanguard Group Inc | 13G/A | 0.00%0 shares | −5.21 ppfrom 5.21%Below 5% | Mar 13, 2026 | SEC |
| Mar 6, 202612:57 PM ET | T. Rowe Price Investment Management, Inc. | 13G | 11.30%6.21M shares | New | Feb 28, 2026 | SEC |
| Feb 17, 20268:27 AM ET | RTW Investments, LPand 1 other | 13G/A | 4.90%2.71M shares | −1.10 ppfrom 6.00%Below 5% | Dec 31, 2025 | SEC |
| Feb 10, 202611:23 AM ET | Wellington Management Group LLPand 3 others | 13G/A | 8.70%4.75M shares | −1.90 ppfrom 10.60% | Dec 31, 2025 | SEC |
| Jan 30, 20261:28 PM ET | Vanguard Group Inc | 13G | 5.21%2.86M shares | New | Dec 31, 2025 | SEC |
| Jan 22, 20268:00 PM ET | Fairmount Funds Management LLCand 3 others | 13D/A | 9.99%6.05M shares | 0.00 ppfrom 9.99% | Jan 22, 2026 | SEC |
| Nov 14, 20257:27 AM ET | Driehaus Capital Management LLC | 13G/A | 4.68%2.16M shares | –Below 5% | Sep 30, 2025 | SEC |
| Oct 14, 20257:11 PM ET | Fairmount Funds Management LLCand 3 others | 13D/A | 9.99%5.78M shares | – | Oct 10, 2025 | SEC |
| Aug 6, 202511:51 AM ET | FMR LLCand 1 other | 13G/A | 15.00%6.91M shares | – | Jun 30, 2025 | SEC |
| Aug 5, 20251:44 PM ET | Wellington Management Group LLPand 3 others | 13G/A | 10.60%4.89M shares | +2.30 ppfrom 8.30% | Jul 31, 2025 | SEC |
| Aug 5, 20251:35 PM ET | Wellington Management Group LLPand 3 others | 13G/A | 8.30%3.81M shares | −3.60 ppfrom 11.90% | Jun 30, 2025 | SEC |
| Jul 16, 20257:02 PM ET | BlackRock, Inc. | 13G/A | 5.50%2.52M shares | – | Jun 30, 2025 | SEC |
| May 12, 202510:44 AM ET | Wellington Management Group LLPand 3 others | 13G/A | 11.90%5.49M shares | – | Mar 31, 2025 | SEC |
| Feb 14, 20259:00 AM ET | RTW Investments, LPand 1 other | 13G | 6.00%2.71M shares | New | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Apogee Therapeutics, Inc. shares.
No Form 144 notices for Apogee Therapeutics, Inc. are on file.